Detalhe da pesquisa
1.
Targeting aberrant glutathione metabolism to eradicate human acute myelogenous leukemia cells.
J Biol Chem
; 288(47): 33542-33558, 2013 Nov 22.
Artigo
Inglês
| MEDLINE | ID: mdl-24089526
2.
The biologic properties of leukemias arising from BCR/ABL-mediated transformation vary as a function of developmental origin and activity of the p19ARF gene.
Blood
; 112(10): 4184-92, 2008 Nov 15.
Artigo
Inglês
| MEDLINE | ID: mdl-18755985
3.
Aberrant eukaryotic translation initiation factor 4E-dependent mRNA transport impedes hematopoietic differentiation and contributes to leukemogenesis.
Mol Cell Biol
; 23(24): 8992-9002, 2003 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-14645512
4.
BCL-2 inhibition targets oxidative phosphorylation and selectively eradicates quiescent human leukemia stem cells.
Cell Stem Cell
; 12(3): 329-41, 2013 Mar 07.
Artigo
Inglês
| MEDLINE | ID: mdl-23333149
5.
Gene sets identified with oncogene cooperativity analysis regulate in vivo growth and survival of leukemia stem cells.
Cell Stem Cell
; 11(3): 359-72, 2012 Sep 07.
Artigo
Inglês
| MEDLINE | ID: mdl-22863534
6.
Leukemia stem cells in a genetically defined murine model of blast-crisis CML.
Blood
; 110(7): 2578-85, 2007 Oct 01.
Artigo
Inglês
| MEDLINE | ID: mdl-17601986